Primary mucinous epithelial ovarian carcinoma in a patient with ankylosing spondylitis treated with infiiximab: Case report Infliksimab ile tedavi edilen ankilozan spondilitli bir hastada primer müsinöz epitelyal over karsinomu

Dikmen Y., TEREK M. C., Sanhal C. Y., ERGENOĞLU A. M., YENİEL A. Ö., ZEKİOĞLU O., ...More

Turkiye Klinikleri Journal of Medical Sciences, vol.33, no.1, pp.238-240, 2013 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.5336/medsci.2011-23682
  • Journal Name: Turkiye Klinikleri Journal of Medical Sciences
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.238-240
  • Keywords: Ankylosing, Infliximab, Ovarian neoplasms, Spondylitis, Tumor necrosis factor alpha (36-68)
  • Akdeniz University Affiliated: Yes

Abstract

Ankylosing spondylitis (AS), the prototype of spondyloarthritis is a chronic inflammatory rheumatic disease with a prevalence of 0.5-1.9% among all types of spondyloarthritis. Inhibition of the proinflammatory cytokine tumour necrosis factor (TNF)-α has demonstrated efficacy in patients with active AS. However, de novo malignancies have been reported in some patients undergoing this therapy representing a major concern. Here, we reported a case with AS who was diagnosed with carcinoma of ovary after receiving therapy with infliximab. Copyright © 2013 by Türkiye Klinikleri.